Pharmafile Logo
Pharmafocus logo
Advanced Search

BMS

Showing 15 posts of 286 posts found.

Lilly image

Lilly diabetes drug beats rivals

June 25, 2013
Sales and Marketing BMS, diabetes, dulaglutide, lilly

New clinical trial results have shown Lilly’s investigational type 2 diabetes drug has beaten its three nearest rivals in reducing …

News
dinesh_c

BMS appoints Harman International chief executive

June 24, 2013
Manufacturing and Production, Research and Development, Sales and Marketing BMS

Bristol-Myers Squibb has appointed Harman’s chief executive Dinesh Paliwal to its Board of directors.Paliwal will serve as a member of …

Appointment
Abilify image

NICE thumbs-up for Abilify

June 7, 2013
Sales and Marketing Abilify, BMS, NICE, Otsuka

Adolescents who suffer from bipolar disorder should be treated on the NHS with Otsuka Pharmaceuticals’ Abilify, according to draft guidance …

News
astrazeneca image

AstraZeneca/BMS drug granted speedy FDA review

June 5, 2013
Sales and Marketing AstraZeneca, BMS, lipodystrophy

AstraZeneca and partner Bristol-Myers Squibb have been granted a priority review for their rare disease drug metreleptin. The medicine is …

News
Merck image

HCV agreement for Merck and BMS

April 23, 2013
Research and Development, Sales and Marketing BMS, HCV, Merck

Merck & Co and Bristol-Myers Squibb have signed a non-exclusive agreement to conduct a Phase II trial looking at a …

News

Bristol-Myers Squibb appoints executive as another retires

April 10, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS

Bristol-Myers Squibb has announced the appointment of Francis Cuss as executive VP and chief scientific officer following Elliott Sigal’s intentions …

Appointment

Merck KGaA/BMS China deal

March 22, 2013
Sales and Marketing BMS, Merck KGaA, diabetes

Merck KGaA and Bristol-Myers Squibb are to co-promote the German firm’s veteran diabetes drug Glucophage in different formations in China. …

News
Eliquis image

Eliquis approved by NICE

February 28, 2013
Sales and Marketing BMS, Eliquis, NICE, Pfizer

In a move which will cheer Bristol-Myers Squibb and Pfizer, NICE has recommended oral blood-thinner Eliquis for use on the …

News

BMS hires Ann Powell Judge from Shire

February 14, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann Powell Judge, BMS, Shire

BMS has announced that Ann Powell Judge will join the company as senior vice president, Human Resources.From March Judge will …

Appointment
BMS image

BMS in $438m OTC deal

February 14, 2013
Sales and Marketing BMS, Reckitt Benckiser

Bristol-Myers Squibb has signed over the rights to sell, distribute and market half a dozen of its medicines, mainly sold …

News
Forxiga image

NICE rejects Forxiga

February 1, 2013
Sales and Marketing AstraZeneca, BMS, Forxiga, NICE, diabetes

NICE has given the thumbs-down to AstraZeneca and Bristol-Myers Squibb’s first-in-class type II diabetes treatment Forxiga. The drug was approved …

News
ec-burgess_1000px

Roche’s Burgess to head up discovery at BMS

January 18, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Burgess

Bristol-Myers Squibb has appointed Mike Burgess as senior vice president, Discovery Medicine and Clinical Pharmacology. He will report to Francis …

Appointment
Eliquis image

Eliquis in UK for AF

December 13, 2012
Sales and Marketing AF, BMS, Eliquis, NVAF, Pfizer

Eliquis has been made available in the UK today to prevent stroke and systemic embolism in patients with nonvalvular atrial …

News
Eliquis image

Further indications for Eliquis

November 22, 2012
Sales and Marketing BMS, Eliquis, NVAF, Pfizer, Pradaxa, Xarelto

Bristol-Myers Squibb and Pfizer’s oral blood-thinner Eliquis has been approved in Europe to prevent stroke in patients with nonvalvular atrial …

News
Forxiga image

Forxiga approved in European Union

November 15, 2012
Sales and Marketing AstraZeneca, BMS, Forxiga, diabetes

AstraZeneca and Bristol-Myers Squibb’s first-in-class type II diabetes treatment Forxiga has been approved in Europe – a major filip for …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026